Comparing headache characteristics in patients with different flexion-rotation test results
Differences in Headache Characteristics of a Subgroup of Cervicogenic Headache Patients With a Positive or Negative FRT: a Cross-sectional Comparison.
This study is trying to see how headaches are different in people with cervicogenic headaches based on whether their flexion-rotation test results are positive or negative.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Ghent Academic / other |
| Locations | 1 site (Ghent, Oost-Vlaanderen) |
| Trial ID | NCT06134791 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the differences in headache characteristics between cervicogenic headache patients who have a positive versus a negative flexion-rotation test at the C1-C2 level. By analyzing these differences, the study seeks to inform future treatment strategies and promote more individualized care for patients suffering from headaches. The flexion-rotation test is a clinical assessment that may reveal important insights into the relationship between cervical spine function and headache intensity. The findings could potentially enhance the understanding of cervicogenic headaches and guide therapeutic interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with cervicogenic headache and experience headaches at least once a week.
Not a fit: Patients with headaches not classified as cervicogenic or those with other underlying conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more tailored treatment options for patients with cervicogenic headaches.
How similar studies have performed: While this approach is based on established clinical tests, the specific comparison of headache characteristics based on flexion-rotation test results is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of cervicogenic headache according to the ICHD-3 criteria: A. Any headache fulfilling criterion C B. Clinical and/or imaging evidence1 of a disorder or lesion within the cervical spine or soft tissues of the neck, known to be able to cause headache2 C. Evidence of causation demonstrated by at least two of the following: * headache has developed in temporal relation to the onset of the cervical disorder or appearance of the lesion * headache has significantly improved or resolved in parallel with improvement in or resolution of the cervical disorder or lesion * cervical range of motion is reduced, and headache is made significantly worse by provocative manœuvres * headache is abolished following diagnostic blockade of a cervical structure or its nerve supply D. Not better accounted for by another ICHD-3 diagnosis Age: 18+ years Headache for at least 1 day/week for at least 3 months Limited mobility of the neck NPRS \> 3/10 Exclusion Criteria: * Primary headache forms: migraine, TTH * Other secondary headaches that do not comply with the ICDH-3 criteria for CH * Whiplash or other traumatic incident in the past * Pregnancy or given birth in the last year * Previous head, neck or shoulder surgery * Cervical radiculopathy complaints * Receiving other treatments for headache or neck pain (physical therapy/ostheopathy/chiropraxie...) in the previous month
Where this trial is running
Ghent, Oost-Vlaanderen
- University Ghent - campus UZ Ghent - Rehabilitation Sciences B3 — Ghent, Oost-Vlaanderen, Belgium (Recruiting)
Study contacts
- Principal investigator: Barbara Cagnie, Prof. dr. — University Ghent
- Study coordinator: Barbara Cagnie, Prof. dr.
- Email: Barbara.Cagnie@Ugent.be
- Phone: +32 9 332 52 6
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.